SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
30 hedge funds and large institutions have $5.77M invested in Sophiris Bio, Inc. in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
94% less call options, than puts
Call options by funds: $1K | Put options by funds: $18K
Holders
30
Holding in Top 10
1
Calls
$1K
Puts
$18K
Top Buyers
| 1 | +$491K | |
| 2 | +$326K | |
| 3 | +$248K | |
| 4 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
+$28K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.9K |
Top Sellers
| 1 | -$729K | |
| 2 | -$78.5K | |
| 3 | -$56K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$41K |
| 5 |
Millennium Management
New York
|
-$32.2K |